APC and diffuse large B-cell lymphoma: Mechanistic analysis showed that circEAF2 specifically targets EBV-encoded miR-BART19-3p, upregulates APC, suppresses downstream β-catenin expression, and counteracts EBV + DLBCL progression [90].